Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
37,274,984
-
Shares change
-
+5,345,565
-
Total reported value, excl. options
-
$823,022,807
-
Value change
-
+$107,488,715
-
Put/Call ratio
-
141%
-
Number of buys
-
77
-
Number of sells
-
-41
-
Price
-
$22.08
Significant Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q1 2021
146 filings reported holding TCRR - TCR2 THERAPEUTICS INC - COM as of Q1 2021.
TCR2 THERAPEUTICS INC - COM (TCRR) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,274,984 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,936,094 shares), MPM ASSET MANAGEMENT LLC (4,050,865 shares), Redmile Group, LLC (3,610,788 shares), MPM Oncology Impact Management LP (3,370,982 shares), BlackRock Inc. (3,066,636 shares), STATE STREET CORP (2,188,354 shares), VANGUARD GROUP INC (1,371,503 shares), VICTORY CAPITAL MANAGEMENT INC (1,231,400 shares), ArrowMark Colorado Holdings LLC (963,606 shares), and Cormorant Asset Management, LP (900,000 shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.